spironolactone has been researched along with Empty Sella Syndrome in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Empty Sella Syndrome: A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here we report a patient with Bartter's syndrome and empty sella." | 1.32 | Association of Bartter's syndrome and empty sella. ( Ertekin, V; Orbak, Z; Selimoglu, AM, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ertekin, V | 1 |
| Selimoglu, AM | 1 |
| Orbak, Z | 1 |
1 other study available for spironolactone and Empty Sella Syndrome
| Article | Year |
|---|---|
Association of Bartter's syndrome and empty sella.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome; Blood Pressure; Empty Sella Syndrome; Hum | 2003 |